DTIL · Company research
Precision BioSciences, Inc. Common Stock (DTIL): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Precision BioSciences (DTIL) Short Interest & Short Float | Updated Oct 2026 $DTIL - MarketBeat | Precision BioSciences (DTIL) Short Interest & Short Float | Updated Oct 2026 $DTIL MarketBeat | View source ↗ | MarketBeat | Oct 9, 2026 | neutral | 0 | 0.6 |
| A gene-editing approach to hepatitis B is set for a late-breaking talk - Stock Titan | A gene-editing approach to hepatitis B is set for a late-breaking talk Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| Understanding Momentum Shifts in (DTIL) - Stock Traders Daily | Understanding Momentum Shifts in (DTIL) Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 7, 2026 | neutral | 0 | 0.6 |
| Precision BioSciences stock fell 3.25 percent during biotech event - AD HOC NEWS | Precision BioSciences stock fell 3.25 percent during biotech event AD HOC NEWS | View source ↗ | AD HOC NEWS | Oct 7, 2026 | neutral | 0 | 0.6 |
| A gene-editing treatment for Duchenne muscular dystrophy doses its first patient - Stock Titan | A gene-editing treatment for Duchenne muscular dystrophy doses its first patient Stock Titan | View source ↗ | Stock Titan | Aug 24, 2026 | neutral | 0 | 0.6 |
| Precision BioSciences: Promising HBV Editing Evidence (NASDAQ:DTIL) - Seeking Alpha | Precision BioSciences: Promising HBV Editing Evidence (NASDAQ:DTIL) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 18, 2026 | neutral | 0 | 0.6 |
| Precision BioSciences (DTIL) Stock Faces Dilution Risk As Revenue Fades - Simply Wall Street | Precision BioSciences (DTIL) Stock Faces Dilution Risk As Revenue Fades Simply Wall Street | View source ↗ | Simply Wall Street | Aug 8, 2026 | neutral | 0 | 0.6 |
| Precision BioSciences (NASDAQ:DTIL) Passes Minervini Trend Template and High-Growth Momentum Screen - ChartMill | Precision BioSciences (NASDAQ:DTIL) Passes Minervini Trend Template and High-Growth Momentum Screen ChartMill | View source ↗ | ChartMill | Aug 8, 2026 | neutral | 0 | 0.6 |
| Precision BioSciences Grants Stock Units to New Employees Amid G - GuruFocus | Precision BioSciences Grants Stock Units to New Employees Amid G GuruFocus | View source ↗ | GuruFocus | Jul 10, 2026 | neutral | 0 | 0.6 |
| Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength? - Yahoo Finance | Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 8, 2026 | neutral | 0 | 0.6 |
| DTIL Forecast — Price Target — Prediction for 2027 - TradingView | DTIL Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Why Is Precision BioSciences Stock Gaining Wednesday? - Precision BioSciences (NASDAQ:DTIL) - Benzinga | Why Is Precision BioSciences Stock Gaining Wednesday? - Precision BioSciences (NASDAQ:DTIL) Benzinga | View source ↗ | Benzinga | May 27, 2026 | neutral | 0 | 0.6 |
| Precision BioSciences stock jumps on hepatitis B trial data - Investing.com | Precision BioSciences stock jumps on hepatitis B trial data Investing.com | View source ↗ | Investing.com | May 27, 2026 | neutral | 0 | 0.6 |
| Should You Buy Precision BioSciences (DTIL) After Golden Cross? - Yahoo Finance | Should You Buy Precision BioSciences (DTIL) After Golden Cross? Yahoo Finance | View source ↗ | Yahoo Finance | Apr 14, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.